journal
https://read.qxmd.com/read/33844977/-in-an-ocean-of-ashes-islands-of-order-who-s-sars-cov-2-origin-report
#1
EDITORIAL
The Lancet Infectious Diseases
No abstract text is available yet for this article.
April 9, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33836161/new-regimens-of-benznidazole-monotherapy-and-in-combination-with-fosravuconazole-for-treatment-of-chagas-disease-bendita-a-phase-2-double-blind-randomised-trial
#2
Faustino Torrico, Joaquim Gascón, Fabiana Barreira, Bethania Blum, Igor C Almeida, Cristina Alonso-Vega, Tayná Barboza, Graeme Bilbe, Erika Correia, Wilson Garcia, Lourdes Ortiz, Rudy Parrado, Juan Carlos Ramirez, Isabela Ribeiro, Nathalie Strub-Wourgaft, Michel Vaillant, Sergio Sosa-Estani
BACKGROUND: Current treatment for Chagas disease with the only available drugs, benznidazole or nifurtimox, has substantial limitations, including long treatment duration and safety and tolerability concerns. We aimed to evaluate the efficacy and safety of new benznidazole monotherapy regimens and combinations with fosravuconazole, in the treatment of Chagas disease. METHODS: We did a double-blind, double-dummy, phase 2, multicentre, randomised trial in three outpatient units in Bolivia...
April 6, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33836160/parasitological-cure-in-children-infected-with-trypanosoma-cruzi
#3
Leonardo M Leony, Fred L N Santos
No abstract text is available yet for this article.
April 6, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33836159/new-treatment-regimens-for-chagas-disease-light-at-the-end-of-the-tunnel
#4
Carlos A Morillo, Luis E Echeverria
No abstract text is available yet for this article.
April 6, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33836158/correction-to-lancet-infect-dis-2021-published-onlinefeb-1-https-doi-org-10-1016-s1473-3099-20-30738-6
#5
(no author information available yet)
No abstract text is available yet for this article.
April 6, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33836157/prediction-of-parasitological-cure-in-children-infected-with-trypanosoma-cruzi-using-a-novel-multiplex-serological-approach-an-observational-retrospective-cohort-study
#6
Laura Jurado Medina, Emeric Chassaing, Griselda Ballering, Nicolas Gonzalez, Lola Marqué, Peter Liehl, Hans Pottel, Jasper de Boer, Eric Chatelain, Maan Zrein, Jaime Altcheh
BACKGROUND: Assessment of therapeutic response with standard serological diagnostic assays in patients with chronic Chagas disease is a major challenge due to the long persistence of parasite-specific antibodies. The current consensus for parasitological cure is to monitor conversion from positive to negative Trypanosoma cruzi serology (seroreversion). However, because of robust humoral immune response, seroreversion by standard serological tests can take years to decades. Developing novel tests of parasitological cure or surrogates is thus a priority in the Chagas disease field...
April 6, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33811817/prioritising-covid-19-vaccination-in-changing-social-and-epidemiological-landscapes-a-mathematical-modelling-study
#7
Peter C Jentsch, Madhur Anand, Chris T Bauch
BACKGROUND: During the COVID-19 pandemic, authorities must decide which groups to prioritise for vaccination in a shifting social-epidemiological landscape in which the success of large-scale non-pharmaceutical interventions requires broad social acceptance. We aimed to compare projected COVID-19 mortality under four different strategies for the prioritisation of SARS-CoV-2 vaccines. METHODS: We developed a coupled social-epidemiological model of SARS-CoV-2 transmission in which social and epidemiological dynamics interact with one another...
March 31, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33811816/correction-to-lancet-infect-dis-2020-published-online-march-25-https-doi-org-10-1016-s1473-3099-21-00151-1
#8
(no author information available yet)
No abstract text is available yet for this article.
March 31, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33811815/the-interplay-between-covid-19-restrictions-and-vaccination
#9
Chad R Wells, Alison P Galvani
No abstract text is available yet for this article.
March 31, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33798488/moxidectin-an-ally-to-ivermectin-for-treating-strongyloides-stercoralis
#10
Zeno Bisoffi, Dora Buonfrate
No abstract text is available yet for this article.
March 30, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33798487/efficacy-and-safety-of-ascending-doses-of-moxidectin-against-strongyloides-stercoralis-infections-in-adults-a-randomised-parallel-group-single-blinded-placebo-controlled-dose-ranging-phase-2a-trial
#11
Daniela Hofmann, Somphou Sayasone, Khanpaseuth Sengngam, Bounthunh Chongvilay, Jan Hattendorf, Jennifer Keiser
BACKGROUND: Strongyloidiasis represents a major public health issue, particularly in resource-limited countries. Preliminary studies suggest that moxidectin might serve as an alternative to the only available treatment option, ivermectin. We aimed to evaluate the efficacy and safety of ascending doses of moxidectin in Strongyloides stercoralis-infected patients. METHODS: We did a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial in four villages in northern Laos...
March 30, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33798486/post-disruption-catch-up-of-child-immunisation-and-health-care-services-in-bangladesh
#12
LETTER
Shohel Rana, Rashed Shah, Sabbir Ahmed, Golam Mothabbir
No abstract text is available yet for this article.
March 30, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33773620/the-effect-of-seasonal-respiratory-virus-transmission-on-syndromic-surveillance-for-covid-19-in-ontario-canada
#13
Arjuna S Maharaj, Jennifer Parker, Jessica P Hopkins, Effie Gournis, Isaac I Bogoch, Benjamin Rader, Christina M Astley, Noah Ivers, Jared B Hawkins, Nancy VanStone, Ashleigh R Tuite, David N Fisman, John S Brownstein, Lauren Lapointe-Shaw
No abstract text is available yet for this article.
March 25, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33773619/congenital-malformations-in-sub-saharan-africa-warnings-of-a-silent-epidemic
#14
Ali Sié, Johanna Hanefeld, Mike Chaponda, R Matthew Chico, Kirsty LeDoare, Philippe Mayaud, Jan Felix Drexler, Thomas Jaenisch
No abstract text is available yet for this article.
March 25, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33773618/performance-and-operational-feasibility-of-antigen-and-antibody-rapid-diagnostic-tests-for-covid-19-in-symptomatic-and-asymptomatic-patients-in-cameroon-a-clinical-prospective-diagnostic-accuracy-study
#15
Yap Boum, Karl Njuwa Fai, Birgit Nicolay, Akenji Blaise Mboringong, Lisa M Bebell, Mark Ndifon, Aristide Abbah, Rachel Essaka, Lucrèce Eteki, Francisco Luquero, Céline Langendorf, Nicole Fouda Mbarga, Rene Ghislain Essomba, Bongkiyung Donald Buri, Tchoula Mamiafo Corine, Bertrand Tchualeu Kameni, Nadia Mandeng, Mahamat Fanne, Anne-Cécile Zoung-Kani Bisseck, Clement B Ndongmo, Sara Eyangoh, Achta Hamadou, Jean Patrick Ouamba, Modeste Tamakloé Koku, Richard Njouom, Okomo Marie Claire, Linda Esso, Emilienne Epée, Georges Alain Etoundi Mballa
BACKGROUND: Real-time PCR is recommended to detect SARS-CoV-2 infection. However, PCR availability is restricted in most countries. Rapid diagnostic tests are considered acceptable alternatives, but data are lacking on their performance. We assessed the performance of four antibody-based rapid diagnostic tests and one antigen-based rapid diagnostic test for detecting SARS-CoV-2 infection in the community in Cameroon. METHODS: In this clinical, prospective, diagnostic accuracy study, we enrolled individuals aged at least 21 years who were either symptomatic and suspected of having COVID-19 or asymptomatic and presented for screening...
March 25, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33773617/rolling-out-covid-19-antigen-rapid-diagnostic-tests-the-time-is-now
#16
Rosanna W Peeling, Piero Olliaro
No abstract text is available yet for this article.
March 25, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33773112/is-there-space-for-a-three-dose-vaccine-to-fight-the-spread-of-sars-cov-2
#17
Patrick L Iversen, Sina Bavari
No abstract text is available yet for this article.
March 24, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33773111/safety-and-immunogenicity-of-a-recombinant-tandem-repeat-dimeric-rbd-based-protein-subunit-vaccine-zf2001-against-covid-19-in-adults-two-randomised-double-blind-placebo-controlled-phase-1-and-2-trials
#18
Shilong Yang, Yan Li, Lianpan Dai, Jianfeng Wang, Peng He, Changgui Li, Xin Fang, Chenfei Wang, Xiang Zhao, Enqi Huang, Changwei Wu, Zaixin Zhong, Fengze Wang, Xiaomin Duan, Siyu Tian, Lili Wu, Yan Liu, Yi Luo, Zhihai Chen, Fangjun Li, Junhua Li, Xian Yu, Hong Ren, Lihong Liu, Shufang Meng, Jinghua Yan, Zhongyu Hu, Lidong Gao, George F Gao
BACKGROUND: Although several COVID-19 vaccines have been developed so far, they will not be sufficient to meet the global demand. Development of a wider range of vaccines, with different mechanisms of action, could help control the spread of SARS-CoV-2 globally. We developed a protein subunit vaccine against COVID-19 using a dimeric form of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein as the antigen. We aimed to assess the safety and immunogenicity of this vaccine, ZF2001, and determine the appropriate dose and schedule for an efficacy study...
March 24, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33770535/food-for-thought-addressing-undernutrition-to-end-tuberculosis
#19
REVIEW
Pranay Sinha, Knut Lönnroth, Anurag Bhargava, Scott K Heysell, Sonali Sarkar, Padmini Salgame, William Rudgard, Delia Boccia, Daniel Van Aartsen, Natasha S Hochberg
Tuberculosis is the leading cause of deaths from an infectious disease worldwide. WHO's End TB Strategy is falling short of several 2020 targets. Undernutrition is the leading population-level risk factor for tuberculosis. Studies have consistently found that undernutrition is associated with increased tuberculosis incidence, increased severity, worse treatment outcomes, and increased mortality. Modelling studies support implementing nutritional interventions for people living with tuberculosis and those at risk of tuberculosis disease to ensure the success of the End TB Strategy...
March 23, 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/33770534/measuring-health-care-delays-among-privately-insured-patients-with-tuberculosis-in-the-usa-an-observational-cohort-study
#20
Jessica El Halabi, Nathan Palmer, Michael McDuffie, Jonathan J Golub, Kathe Fox, Isaac Kohane, Maha R Farhat
BACKGROUND: A high index of suspicion is needed to initiate appropriate testing for tuberculosis due to its protean symptoms, yet health-care providers in low-incidence settings are becoming less familiar with the disease as rates decline. We aimed to estimate delays in tuberculosis diagnosis and treatment at the US national level between 2008 and 2016. METHODS: In this retrospective observational cohort study, we repurposed private insurance claims data provided by Aetna (Connecticut, USA), to measure health-care delays in tuberculosis diagnosis in the USA in 2008-16...
March 23, 2021: Lancet Infectious Diseases
journal
journal
20187
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"